Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.

Abstract

BACKGROUND:

Meningioma arising from meninges is one among the various types of brain tumors. Others are, astrocytomas originating from astrocyte, oligodendrogliomas originating from oligodendrocyte, Ependymomas originating from ependymal cells and medulloblastomas originating from neurons. Current knowledge of molecular biology, genetics and epigenetics of meningioma is not sufficient. Therefore, In depth understanding of the mechanism of meningioma formation and progression is needed for its treatment and management. Grade I Grade I meningiomas are majorly classified as grade I, grade II and grade III. Meningioma can be indolent, slow growing or can be invasive and metastatic which can recurre. Grade I meningioma can be removed by surgery in comparison to invasive meningioma which may recurre with high propensity. This property of recurrence is responsible for high morbidity and mortality. Meningioma are majorly classified into three classes namely grade I, grade II, grade III. Protein biomarkers are considered as promising candidates for the diagnosis of meningioma.

STUDY:

Various studies done on differential expression of proteins have shown increased expression of EGFR, NEK9, EPS812, CKAP4, SET and STAT2, in all the three grades of meningioma. Additionally, some proteins like HK2 are overexpressed in grade II and grade III meningioma than in grade I meningioma. Protein Markers, found on extracellular vesicles of different grades of meningioma can serve the same purpose. A test done on a sample of any kind of body fluid like blood, tear, saliva, urine etc. for recognizing the circulating cancer cells or DNA and extracellular vesicles released from them to help detecting the early stage of cancer is known as liquid biopsy. Solid biopsy has several limitations as compared to liquid biopsy. This is because the samples can be easily collected and studied in case of liquid biopsy. Exosomes are related with liquid biopsy and hence provide platform for better diagnosis, prognosis and treatment of any type of cancer including meningioma. Exosomal tetraspanin are important example of exosomal biomarkers. The tetraspanin network is a molecular scaffold which connects various proteins for signal transduction.

CONCLUSION:

This study tells about the utility of proper knowledge of extracellular vesicle proteins and their profiles in different grades, which can help in better understanding of pathogenesis, diagnosis, prognosis and treatment of meningioma. In Addition to use of these proteins as biomarkers, role of exosomes in currently available therapeutic approaches has been discussed.

• Authors: Rashmi Rana, Swati Sharma, Nirmal Kumar Ganguly
• Journal: Molecular biology reports (Mol Biol Rep) Vol. 48 Issue 12 Pg. 8061-8074 (Dec 2021) ISSN: 1573-4978 [Electronic] Netherlands
• PMID: 34687392 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Chemical References

• Biomarkers, Tumor
• Tetraspanins

Topics

• Biomarkers, Tumor (metabolism)
• Brain Neoplasms (genetics)
• Drug Delivery Systems (methods)
• Exosomes (metabolism)
• Extracellular Vesicles (genetics, metabolism, physiology)
• Humans
• Liquid Biopsy (methods)
• Meningioma (drug therapy, genetics, pathology)
• Neoplasm Grading (methods)
• Prognosis
• Proteomics (methods)
• Tetraspanins (metabolism)